MARATTO

article · Cancer Chemotherapy and Pharmacology

Targeting insulin-like growth factor-1 (IGF-1) by using metformin in non-diabetic metastatic breast cancer female patients: a randomized controlled trial

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

  • Metabolism, Diabetes, and Cancer
  • Growth Hormone and Insulin-like Growth Factors
  • Cancer Risks and Factors

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s00280-025-04791-8

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.